Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032

Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A1572
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Oncology Biosimilars Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Drug Type
    5.5    Market Breakup by Cancer Type
    5.6    Market Breakup by Distribution Channel
    5.7    Market Breakup by Region
    5.8    Market Forecast
6   Market Breakup by Drug Type
    6.1    Monoclonal Antibody
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Immunomodulators
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    G-CSF 
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Hematopoietic Agents
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Others  
        6.5.1    Market Trends
        6.5.2    Market Forecast
7   Market Breakup by Cancer Type
    7.1    Lung Cancer
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Colorectal Cancer
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Cervical Cancer
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Breast Cancer
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Kidney Cancer
        7.5.1    Market Trends
        7.5.2    Market Forecast
    7.6    Stomach Cancer
        7.6.1    Market Trends
        7.6.2    Market Forecast
    7.7    Brain Cancer
        7.7.1    Market Trends
        7.7.2    Market Forecast
    7.8    Others
        7.8.1    Market Trends
        7.8.2    Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacies
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Online Pharmacies
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Retail Pharmacies
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Others
        8.4.1    Market Trends
        8.4.2    Market Forecast
9   Market Breakup by Region
    9.1    Europe
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Asia Pacific
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    North America
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Biocon Limited
        14.3.2    Celltrion Inc.
        14.3.3    Dr. Reddy's Laboratories Ltd.
        14.3.4    Intas Pharmaceuticals Ltd.
        14.3.5    STADA Arzneimittel AG
        14.3.6    Pfizer Inc.
        14.3.7    Apotex Inc.
        14.3.8    Teva Pharmaceutical Industries Ltd.
        14.3.9    Sandoz International GmbH
        14.3.10     BIOCAD Biotechnology Company
        14.3.11     Mylan N.V.
        14.3.12     F. Hoffmann-La Roche AG

List of Figures

Figure 1: Global: Oncology Biosimilars Market: Major Drivers and Challenges
Figure 2: Global: Oncology Biosimilars Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Oncology Biosimilars Market: Breakup by Drug Type (in %), 2023
Figure 4: Global: Oncology Biosimilars Market: Breakup by Cancer Type (in %), 2023
Figure 5: Global: Oncology Biosimilars Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Oncology Biosimilars Market: Breakup by Region (in %), 2023
Figure 7: Global: Oncology Biosimilars Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Oncology Biosimilars Industry: SWOT Analysis
Figure 9: Global: Oncology Biosimilars Industry: Value Chain Analysis
Figure 10: Global: Oncology Biosimilars Industry: Porter’s Five Forces Analysis
Figure 11: Global: Oncology Biosimilars (Monoclonal Antibody) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Oncology Biosimilars (Monoclonal Antibody) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Oncology Biosimilars (Immunomodulators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Oncology Biosimilars (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Oncology Biosimilars (G-CSF) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Oncology Biosimilars (G-CSF) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Oncology Biosimilars (Hematopoietic Agents) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Oncology Biosimilars (Hematopoietic Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Oncology Biosimilars (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Oncology Biosimilars (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Oncology Biosimilars (Lung Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Oncology Biosimilars (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Oncology Biosimilars (Colorectal Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Oncology Biosimilars (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Oncology Biosimilars (Cervical Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Oncology Biosimilars (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Oncology Biosimilars (Breast Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Oncology Biosimilars (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Oncology Biosimilars (Kidney Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Oncology Biosimilars (Kidney Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Oncology Biosimilars (Stomach Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Oncology Biosimilars (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Oncology Biosimilars (Brain Cancer) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Oncology Biosimilars (Brain Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Oncology Biosimilars (Other Cancer Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Oncology Biosimilars (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Oncology Biosimilars Market: Sales through Hospital Pharmacies (in Million US$), 2018 & 2023
Figure 38: Global: Oncology Biosimilars Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2024-2032
Figure 39: Global: Oncology Biosimilars Market: Sales through Online Pharmacies (in Million US$), 2018 & 2023
Figure 40: Global: Oncology Biosimilars Market Forecast: Sales through Online Pharmacies (in Million US$), 2024-2032
Figure 41: Global: Oncology Biosimilars Market: Sales through Retail Pharmacies (in Million US$), 2018 & 2023
Figure 42: Global: Oncology Biosimilars Market Forecast: Sales through Retail Pharmacies (in Million US$), 2024-2032
Figure 43: Global: Oncology Biosimilars Market: Sales through Other Distribution Channels (in Million US$), 2018 & 2023
Figure 44: Global: Oncology Biosimilars Market Forecast: Sales through Other Distribution Channels (in Million US$), 2024-2032
Figure 45: Europe: Oncology Biosimilars Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Europe: Oncology Biosimilars Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Asia Pacific: Oncology Biosimilars Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Asia Pacific: Oncology Biosimilars Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: North America: Oncology Biosimilars Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: North America: Oncology Biosimilars Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Middle East and Africa: Oncology Biosimilars Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Middle East and Africa: Oncology Biosimilars Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Latin America: Oncology Biosimilars Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Latin America: Oncology Biosimilars Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

Table 1: Global: Oncology Biosimilars Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Oncology Biosimilars Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 3: Global: Oncology Biosimilars Market Forecast: Breakup by Cancer Type (in Million US$), 2024-2032
Table 4: Global: Oncology Biosimilars Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Oncology Biosimilars Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Oncology Biosimilars Market Structure
Table 7: Global: Oncology Biosimilars Market: Key Players

Oncology Biosimilars Market Report by Drug Type (Monoclonal Antibody, Immunomodulators, G-CSF, Hematopoietic Agents, and Others), Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More